TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2011

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial.

Luigi Celio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.